NSEDCP
CARM

NJ State Employees Deferred Compensation Plan’s Carisma Therapeutics CARM Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,250
Closed -$70K – 383
2015
Q2 		$70K Hold
1,250
– – 0.01% 372
2015
Q1 		$224K Hold
1,250
– – 0.04% 352
2014
Q4 		$298K Hold
1,250
– – 0.06% 331
2014
Q3 		$278K Hold
1,250
– – 0.06% 337
2014
Q2 		$330K Hold
1,250
– – 0.07% 334
2014
Q1 		$406K Buy
+1,250
New +$374K 0.08% 314

Other funds holding CARM

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's CARM Position: Q3 2015 in Review

NJ State Employees Deferred Compensation Plan sold out of Carisma Therapeutics (CARM) in Q3 2015, closing a stake of 1,250 shares — an estimated $70K sold.

NJ State Employees Deferred Compensation Plan first reported a position in CARM in Q1 2014 and held it in 6 quarters. The position peaked at $406K in Q1 2014. 30 funds tracked by Wall St. Rank hold CARM as of Q3 2015.

  • NJ State Employees Deferred Compensation Plan reported no remaining Carisma Therapeutics position as of Q3 2015 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 1,250 Carisma Therapeutics shares in Q3 2015, an estimated $70K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Carisma Therapeutics in Q1 2014 and held it in 6 quarters.
  • NJ State Employees Deferred Compensation Plan's Carisma Therapeutics position peaked at $406K in Q1 2014.
  • 30 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q3 2015.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2015, filed 2 Nov 2015.